iSpecimen Prices $5M Offering at $1.30, Deep Discount to Market
ISPC is trading near its 52-week low of $1.77 (2.3% above the low) on light trading volume (0.4× avg).
Summary
iSpecimen priced a $5 million public offering at $1.30 per share, a 28% discount to yesterday's close of $1.81. The deal includes pre-funded warrants and follows a series of dilutive capital raises amid severe cash burn. Proceeds will cover liabilities, potential acquisitions, and working capital. The company is fighting for survival after an 85% revenue drop and a going concern warning. This offering, upsized from the $4 million filed in June, adds to the overhang from the S-3 resale of 101 million shares. Closing is expected August 7.
Updates
· SEC 8-K — The offering closed on August 7, 2026, with 996,231 shares and pre-funded warrants for up to 2,849,923 shares at $1.30 per share, totaling approximately $5.0 million.
At the time of this announcement, ISPC was trading at $1.81 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.9M. The 52-week trading range was $1.77 to $127.20. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.